RvE1 |
Mouse |
Dorsal air pouch |
Stop neutrophil recruitment |
[42] |
|
|
Peritonitis |
Reduce neutrophil recruitment |
[48,59] |
|
|
|
Regulate cytokine and chemokine expression |
[48,59] |
|
|
Retinopathy |
Alleviate neovascularization and reduce TNF-a expression |
[61] |
|
|
Colitis |
Decrease neutrophil recruitment and improve survival |
[62] |
|
|
Allergy |
Resolve allergic airway inflammation |
[63, 64] |
|
|
|
Regulate NK cell migration |
[63, 64] |
|
|
Ocular Lesion |
Control HSV-induced ocular inflammatory lesions |
[65] |
|
|
|
Increase IL-10 and decrease IL-6 expression |
[65] |
|
|
Lung injury |
Protect bacterial pneumonia and acute lung injury |
[66] |
|
|
|
Enhance clearance of bacteria |
[66] |
RvD1 |
Mouse |
Kidney ischemia |
Protect from ischemia-reperfusion-induced kidney damage |
[67] |
|
|
|
Regulate macrophage function |
[67] |
|
|
Peritonitis |
Stop neutrophil recruitment and modulate miRNAs |
[68] |
|
|
Dorsal skin air pouch |
Stop neutrophil recruitment |
[46] |
|
|
Oxidative stress |
Control inflammation during oxidative stress |
[69] |
AT-RvD1 |
Mouse |
TMJ inflammation |
Protect inflammation in the TMJ |
[70] |